All changes for the tissue Anatomical System (4331)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1278
CD38 antigen
Molecular
cochlea
Mouse
Cd38
26.0% Increase Gene Expression Level
DAA1447
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)
Molecular
kidney
Mouse
Cd74
14.0% Increase Gene Expression Level
DAA1701
CD8 antigen, beta chain 1
Molecular
lung
Mouse
Cd8b1
36.0% Increase Gene Expression Level
DAA45
Cdc2-related kinase, arginine/serine-rich
Molecular
brain
Human
CDK12
17.0% Increase Gene Expression Level
DAA408
CDC42 effector protein (Rho GTPase binding) 3
Molecular
skeletal muscle
Human
CDC42EP3
6.0% Increase Gene Expression Level
DAA462
CDK5 regulatory subunit associated protein 3
Molecular
skeletal muscle
Human
CDK5RAP3
4.0% Increase Gene Expression Level
DAA1309
cDNA sequence BC017643
Molecular
hematological system
Mouse
BC017643
9.0% Decrease Gene Expression Level
DAA1251
cDNA sequence BC026782
Molecular
brain
Mouse
BC026782
217.0% Increase Gene Expression Level
DAA1249
cDNA sequence BC037703
Molecular
brain
Mouse
BC037703
809.0% Increase Gene Expression Level
DAA1619
cDNA sequence BC048546
Molecular
lung
Mouse
BC048546
18.0% Increase Gene Expression Level
DAA1858
cDNA sequence D10627
Molecular
skeletal muscle
Mouse
D10627
8.0% Decrease Gene Expression Level
DAA1550
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B
Molecular
liver
Mouse
Cideb
5.0% Decrease Gene Expression Level
DAA95
cell division cycle 2-like 2 (PITSLRE proteins)
Molecular
brain
Human
CDC2L2
27.0% Increase Gene Expression Level
DAA659
Cell number decreases in cartilage
Physiological
cartilage
Human
—
—
DAA695
Cell proliferation increases
Physiological
arterial intima
Human
—
—
DAA704
Cellular hypertrophy in left ventricular wall
Physiological
left ventricle
Human
—
—
DAA1705
cellular repressor of E1A-stimulated genes 1
Molecular
lung
Mouse
Creg1
3.0% Increase Gene Expression Level
DAA557
centromere protein V
Molecular
skeletal muscle
Human
CENPV
4.0% Decrease Gene Expression Level
DAA349
centrosomal protein 350kDa
Molecular
skeletal muscle
Human
CEP350
4.0% Increase Gene Expression Level
DAA2087
centrosomal protein 57kDa increases with age
Molecular
ovary
Human
CEP57
86.0% Increase Gene Expression Level
DAA741
Cerebral blood flow and glucose utilization are reduced
Physiological
brain
Human
—
—
DAA738
Cerebral spinal fluid amount increases
Physiological
brain
Human
—
—
DAA1495
ceruloplasmin
Molecular
kidney
Mouse
Cp
10.0% Increase Gene Expression Level
DAA600
Cervical cancer
Pathological
cervix
Human
—
SeriesMorbidity
DAA995
Change in weave of dermis collagen fibers
Physiological
dermis
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1278 | CD38 antigen | Molecular | cochlea | Mouse | Cd38 | 26.0% Increase Gene Expression Level | |
DAA1447 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | Molecular | kidney | Mouse | Cd74 | 14.0% Increase Gene Expression Level | |
DAA1701 | CD8 antigen, beta chain 1 | Molecular | lung | Mouse | Cd8b1 | 36.0% Increase Gene Expression Level | |
DAA45 | Cdc2-related kinase, arginine/serine-rich | Molecular | brain | Human | CDK12 | 17.0% Increase Gene Expression Level | |
DAA408 | CDC42 effector protein (Rho GTPase binding) 3 | Molecular | skeletal muscle | Human | CDC42EP3 | 6.0% Increase Gene Expression Level | |
DAA462 | CDK5 regulatory subunit associated protein 3 | Molecular | skeletal muscle | Human | CDK5RAP3 | 4.0% Increase Gene Expression Level | |
DAA1309 | cDNA sequence BC017643 | Molecular | hematological system | Mouse | BC017643 | 9.0% Decrease Gene Expression Level | |
DAA1251 | cDNA sequence BC026782 | Molecular | brain | Mouse | BC026782 | 217.0% Increase Gene Expression Level | |
DAA1249 | cDNA sequence BC037703 | Molecular | brain | Mouse | BC037703 | 809.0% Increase Gene Expression Level | |
DAA1619 | cDNA sequence BC048546 | Molecular | lung | Mouse | BC048546 | 18.0% Increase Gene Expression Level | |
DAA1858 | cDNA sequence D10627 | Molecular | skeletal muscle | Mouse | D10627 | 8.0% Decrease Gene Expression Level | |
DAA1550 | cell death-inducing DNA fragmentation factor, alpha subunit-like effector B | Molecular | liver | Mouse | Cideb | 5.0% Decrease Gene Expression Level | |
DAA95 | cell division cycle 2-like 2 (PITSLRE proteins) | Molecular | brain | Human | CDC2L2 | 27.0% Increase Gene Expression Level | |
DAA659 | Cell number decreases in cartilage | Physiological | cartilage | Human | — | — | |
DAA695 | Cell proliferation increases | Physiological | arterial intima | Human | — | — | |
DAA704 | Cellular hypertrophy in left ventricular wall | Physiological | left ventricle | Human | — | — | |
DAA1705 | cellular repressor of E1A-stimulated genes 1 | Molecular | lung | Mouse | Creg1 | 3.0% Increase Gene Expression Level | |
DAA557 | centromere protein V | Molecular | skeletal muscle | Human | CENPV | 4.0% Decrease Gene Expression Level | |
DAA349 | centrosomal protein 350kDa | Molecular | skeletal muscle | Human | CEP350 | 4.0% Increase Gene Expression Level | |
DAA2087 | centrosomal protein 57kDa increases with age | Molecular | ovary | Human | CEP57 | 86.0% Increase Gene Expression Level | |
DAA741 | Cerebral blood flow and glucose utilization are reduced | Physiological | brain | Human | — | — | |
DAA738 | Cerebral spinal fluid amount increases | Physiological | brain | Human | — | — | |
DAA1495 | ceruloplasmin | Molecular | kidney | Mouse | Cp | 10.0% Increase Gene Expression Level | |
DAA600 | Cervical cancer | Pathological | cervix | Human | — | SeriesMorbidity | |
DAA995 | Change in weave of dermis collagen fibers | Physiological | dermis | Human | — | — |